Midwives frequently care for pregnant women who have underlying seizure disorders or who develop acute hypertensive emergencies during gestation. Understanding how central nervous system medications work is essential for safe maternal and fetal outcomes. Anticonvulsants primarily suppress acute, severe seizures like eclampsia, whereas antiepileptics are long-term maintenance drugs used to control chronic seizure conditions such as epilepsy throughout the antenatal period. Differentiating between these drug classes ensures appropriate clinical responses when managing obstetric complications versus chronic neurological diseases.
Magnesium sulphate is the gold-standard drug for preventing and treating convulsions in severe preeclampsia and eclampsia. It acts centrally and peripherally to reduce neuromuscular irritability.
Before every dose, the midwife must check specific clinical parameters to prevent dangerous toxicity. A common mistake is omitting the patellar reflex check, which serves as the earliest clinical indicator of rising serum magnesium levels.
Pregnant women with pre-existing epilepsy must continue their maintenance therapy to avoid status epilepticus, which poses severe hypoxic risks to both mother and fetus. However, many traditional antiepileptic drugs carry intrinsic teratogenic risks. Midwives collaborate closely with medical officers to ensure steady drug titration, encouraging adherence while monitoring for breakthrough seizures triggered by changing pharmacokinetic volumes during pregnancy.
Exposure to certain antiepileptic drugs during organogenesis significantly increases the incidence of congenital anomalies. Major risks include neural tube defects, cardiac malformations, and craniofacial abnormalities, often referred to as fetal hydantoin syndrome when associated with specific medications like phenytoin. Midwives educate women on the critical importance of preconception folic acid supplementation to help mitigate neural tube defect risks associated with these therapies.
Administering central nervous system medications in maternity units requires rigorous, continuous surveillance. Midwives monitor vital signs, hourly urine output, and respiratory rate when managing patients on high-risk infusions. An antidote must always be kept immediately accessible at the bedside whenever magnesium sulphate is in use. Emergency tray preparation ensures swift intervention if respiratory depression or cardiac arrest occurs secondary to drug toxicity.